BioxyneASX:BXNDA -2.06%50 FCF Margin % is -7.25% as of Dec. 2025. GuruFocus rates ASX:BXNDA with a GF Score™ of 50/100 and a GF Value™ of A$0.69 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,956 Consumer Packaged Goods companies, Bioxyne ranks worse than 57.31% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bioxyne's Free Cash Flow for the
six
months ended in Dec. 2025 was A$-2.27 Mil. Bioxyne's Revenue for the
six
months ended in Dec. 2025 was A$31.31 Mil. Therefore, Bioxyne's FCF Margin % for the quarter that ended in Dec. 2025 was -7.25%.
The historical rank and industry rank for Bioxyne's FCF Margin % or its related term are showing as below:
ASX:BXNDA'
s FCF Margin % Range Over the Past 10 Years
Min: -101.71 Med: -11.13 Max: 18.14
Current: 0.6
During the past 13 years, the highest FCF Margin % of Bioxyne was 18.14%. The lowest was -101.71%. And the median was -11.13%.
ASX:BXNDA's FCF Margin % is ranked worse than 57.31% of 1956
companies
in the Consumer Packaged Goods industry
Industry Median: 2.155
vs ASX:BXNDA: 0.60
Bioxyne FCF Margin % Related Terms
Bioxyne FCF Margin % Historical Data
* Premium members only.
The historical data trend for Bioxyne's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Bioxyne's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioxyne FCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioxyne's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bioxyne's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioxyne (ASX:BXNDA) has a FCF Margin % of -7.25% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioxyne and its competitors. According to the industry distribution chart, Bioxyne ranks #1121 out of 1956 companies in the Consumer Packaged Goods industry, placing it in the top 57.3%.
Is Bioxyne's FCF Margin % too high?
Bioxyne's current FCF Margin % is -7.25%. Based on the distribution chart, Bioxyne ranks #1121 out of 1956 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Bioxyne has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bioxyne's FCF Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioxyne ranks #1121 out of 1956 companies for FCF Margin %. This places Bioxyne in the lower half of its industry. The industry median FCF Margin % is 2.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Consumer Packaged Goods company?
The median FCF Margin % among Consumer Packaged Goods companies is 2.16, based on 1,956 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioxyne and its competitors. For the Consumer Packaged Goods industry, the median FCF Margin % is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioxyne's current FCF Margin % is -7.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioxyne stock overvalued right now?
Based on GuruFocus' analysis, Bioxyne (ASX:BXNDA) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.69, compared to a current price of A$0.95 — trading 37.7% above its estimated fair value. The current FCF Margin % is -7.25%. Bioxyne's overall GF Score™ is 50/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bioxyne (ASX:BXNDA), the current FCF Margin % is -7.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioxyne (ASX:BXNDA) Overvalued in 2026?
Based on GuruFocus' analysis, Bioxyne stock appears to be overvalued.
The current stock price of A$0.95 is trading 37.7% above its estimated GF Value™ of A$0.69.
GuruFocus considers Bioxyne to be Significantly Overvalued.
Key valuation signals for ASX:BXNDA:
FCF Margin %: -7.25%
GF Value™: A$0.69 vs. price of A$0.95 (37.7% above fair value)
No single metric tells the full story. See the ASX:BXNDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments, namely, Pharmaceutical manufacture and wholesale supply (business to business), Manufacture and distribution (wholesale, online, and retail), and Wholesale of patented Probiotics.
50GF Score
Get the complete analysis for ASX:BXNDA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BXNDA has been successfully added to your 
